Citation

Stanford M, Jones JA. Acta Astronaut. 1999; 45(1): 39-47.

Affiliation

Center of Aerospace Medicine and Physiology, University of Texas Medical Branch at Galveston 77555, USA.

Copyright

(Copyright © 1999, Elsevier Publishing)

DOI

unavailable

PMID

11542526

Abstract

Spaceflight exposes astronaut crews to natural ionizing radiation. To date, exposures in manned spaceflight have been well below the career limits recommended to NASA by the National Council of Radiation Protection and Measurements (NCRP). This will not be the case for long-duration exploratory class missions. Additionally. International Space Station (ISS) crews will receive higher doses than earlier flight crews. Uncertainties in our understanding of long-term bioeffects, as well as updated analyses of the Hiroshima. Nagasaki and Chernobyl tumorigenesis data, have prompted the NCRP to recommend further reductions by 30-50% for career dose limit guidelines. Intelligent spacecraft design and material selection can provide a shielding strategy capable of maintaining crew exposures within recommended guidelines. Current studies on newer radioprotectant compounds may find combinations of agents which further diminish the risk of radiation-induced bioeffects to the crew.

Language: en